INS and metabolic disease: The world has hitherto been plagued by type 2 diabetes (T2D), a metabolic disorder typically defined by chronic hyperglycemia and glucose intolerance, with concomitant altered metabolism of carbohydrates, fats, and proteins, resulting from inadequate insulin secretion and impaired efficacy of insulin to stimulate glucose uptake [1].